Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Russell Weiner"'
Autor:
Colles Price, Kazuho Nishimura, Michael Zhou, Som Bandyopadhyay, Russell Weiner, Darrell Borger
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 2 (2023)
Externí odkaz:
https://doaj.org/article/a27908ea8ba2496380514d32eda165ee
Publikováno v:
Journal of Circulating Biomarkers, Vol 4 (2015)
Thymus- and activation-regulated chemokine (TARC) in serum/plasma associates with the disease activity of atopic dermatitis (AD), and is a promising tool for assessing the response to the treatment of the disease. TARC also exists within platelets, w
Externí odkaz:
https://doaj.org/article/997715910d724726840f96e6f2734f58
Publikováno v:
PLoS ONE, Vol 8, Iss 8, p e72239 (2013)
Somatic mutations identified on genes related to the cancer-developing signaling pathways have drawn attention in the field of personalized medicine in recent years. Treatments developed to target a specific signaling pathway may not be effective whe
Externí odkaz:
https://doaj.org/article/8cbeba88e47648f88615b3d9d71fc66e
Autor:
Zhen Wang, Wei Zhou, Marisa Dolled-Filhart, Lars Bastholt, Kenneth Emancipator, P. Switten Nielsen, Y. Feng, Torben Steiniche, A. Vestergaard Danielsen, Michael Busch-Sørensen, Henrik Schmidt, Inge Marie Svane, Russell Weiner
Publikováno v:
Steiniche, T, Vestergaard Danielsen, A, Wang, Z, Feng, Y, Switten Nielsen, P, Bastholt, L, Schmidt, H, Svane, I M, Dolled-Filhart, M, Emancipator, K, Weiner, R, Busch-Sørensen, M & Zhou, W 2017, ' PD-L1 expression and survival among melanoma patients treated with standard immunotherapy or chemotherapy ', Journal of the European Academy of Dermatology and Venereology, vol. 31, no. 7, pp. e319–e321 . https://doi.org/10.1111/jdv.14106
Steiniche, T, Vestergaard Danielsen, A, Wang, Z, Feng, Y, Switten Nielsen, P, Bastholt, L, Schmidt, H, Svane, I M, Dolled-Filhart, M, Emancipator, K, Weiner, R, Busch-Sørensen, M & Zhou, W 2017, ' PD-L1 expression and survival among melanoma patients treated with standard immunotherapy or chemotherapy ', Journal of the European Academy of Dermatology and Venereology. Supplement, vol. 31, no. 7, pp. e319-e321 . https://doi.org/10.1111/jdv.14106
Steiniche, T, Vestergaard Danielsen, A, Wang, Z, Feng, Y, Switten Nielsen, P, Bastholt, L, Schmidt, H, Svane, I M, Dolled-Filhart, M, Emancipator, K, Weiner, R, Busch-Sørensen, M & Zhou, W 2017, ' PD-L1 expression and survival among melanoma patients treated with standard immunotherapy or chemotherapy ', Journal of the European Academy of Dermatology and Venereology. Supplement, vol. 31, no. 7, pp. e319-e321 . https://doi.org/10.1111/jdv.14106
The association between programmed death ligand 1 (PD-L1) expression and survival among melanoma patients treated with chemotherapy is unclear.1-5 We retrospectively characterized PD-L1 levels in patients with melanoma treated at Aarhus University Ho
Autor:
Lakshmi Amaravadi, Sriram Subramaniam, Sherri Dudal, Eric Fluhler, Sam H. Haidar, Steve Lowes, Robert Nicholson, Brian Booth, Marie Rock, John Kadavil, Binodh DeSilva, Russell Weiner, Lauren Stevenson, Boris Gorovits, Michael Skelly, Eric Woolf, Mark E. Arnold
Publikováno v:
The AAPS Journal. 17:277-288
In September 2013, the FDA released a draft revision of the Bioanalytical Method Validation (BMV) Guidance, which included a number of changes to the expectations for bioanalysis, most notably the inclusion of biomarker assays and data. To provide a
Publikováno v:
Bioanalysis. 6:1759-1766
Background: Fibrinopeptide A (FPA) is a plasma peptide, formed by the action of thrombin on fibrinogen during clog formation. FPA represents a direct indicator of thrombin activity and could potentially be used as a biomarker for anti-thrombotic ther
Autor:
Russell Weiner, Marian Kelley
This handbook covers established and advanced techniques for biomarker analysis, such as guidelines and strategies for assay validation methods; different mathematical models that are necessary in contemporary drug discovery and development; and eval
Publikováno v:
Bioanalysis. 4:2843-2850
Background: Renin catalyzes the conversion of angiotensinogen to angiotensin I (Ang I), the first and rate-limiting step in the renin–angiotensin–aldosterone system. Plasma renin activity (PRA) is an important target engagement biomarker in the c
Autor:
Marian Kelley, Russell Weiner
Publikováno v:
AAPS Advances in the Pharmaceutical Sciences Series ISBN: 9783319407920
Translating Molecular Biomarkers into Clinical Assays
Translating Molecular Biomarkers into Clinical Assays
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff599443f74d3beb55c39b46cca84171
https://doi.org/10.1007/978-3-319-40793-7
https://doi.org/10.1007/978-3-319-40793-7
Autor:
Marian Kelley, Russell Weiner
Publikováno v:
Translating Molecular Biomarkers into Clinical Assays ISBN: 9783319407920
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::505f4df5b8294c8672cbf1c779603260
https://doi.org/10.1007/978-3-319-40793-7_19
https://doi.org/10.1007/978-3-319-40793-7_19